Options to optimize the access to biosimilars: analysis and solutions
The cost of medical care has been growing around the world; this is due to a number of factors, including the growing use of costly medicines for cancer and rare (orphan) diseases. The introduction of reproduced medicinal products instead of original ones opens the way to medical cost reduction. In...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2018-05-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/230 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849249670699679744 |
|---|---|
| author | O. V. Kirsanova V. V. Omelyanovsky |
| author_facet | O. V. Kirsanova V. V. Omelyanovsky |
| author_sort | O. V. Kirsanova |
| collection | DOAJ |
| description | The cost of medical care has been growing around the world; this is due to a number of factors, including the growing use of costly medicines for cancer and rare (orphan) diseases. The introduction of reproduced medicinal products instead of original ones opens the way to medical cost reduction. In the present study, various aspects of registration and application of reproduced biological medicinal products – biosimilars – in the Russian Federation and elsewhere (USA, EU) are addressed. We propose the basic approaches to optimize the access to biological preparations and their analogs (biosimilars) considering the existing increase in medical costs and the need to maintain the quality of medical care. |
| format | Article |
| id | doaj-art-3b9dbbf54f164ad892576f5f87eb2e69 |
| institution | Kabale University |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| publishDate | 2018-05-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj-art-3b9dbbf54f164ad892576f5f87eb2e692025-08-20T03:57:30ZrusIRBIS LLCФармакоэкономика2070-49092070-49332018-05-01111505510.17749/2070-4909.2018.11.1.050-055210Options to optimize the access to biosimilars: analysis and solutionsO. V. Kirsanova0V. V. Omelyanovsky1Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian FederationResearch Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget Institution Russian Presidential Academy of National Economy and Public Administration, Federal State Educational Institution of Higher Professional EducationThe cost of medical care has been growing around the world; this is due to a number of factors, including the growing use of costly medicines for cancer and rare (orphan) diseases. The introduction of reproduced medicinal products instead of original ones opens the way to medical cost reduction. In the present study, various aspects of registration and application of reproduced biological medicinal products – biosimilars – in the Russian Federation and elsewhere (USA, EU) are addressed. We propose the basic approaches to optimize the access to biological preparations and their analogs (biosimilars) considering the existing increase in medical costs and the need to maintain the quality of medical care.https://www.pharmacoeconomics.ru/jour/article/view/230biosimilarsregistrationreproductionreplaceabilitygenerics |
| spellingShingle | O. V. Kirsanova V. V. Omelyanovsky Options to optimize the access to biosimilars: analysis and solutions Фармакоэкономика biosimilars registration reproduction replaceability generics |
| title | Options to optimize the access to biosimilars: analysis and solutions |
| title_full | Options to optimize the access to biosimilars: analysis and solutions |
| title_fullStr | Options to optimize the access to biosimilars: analysis and solutions |
| title_full_unstemmed | Options to optimize the access to biosimilars: analysis and solutions |
| title_short | Options to optimize the access to biosimilars: analysis and solutions |
| title_sort | options to optimize the access to biosimilars analysis and solutions |
| topic | biosimilars registration reproduction replaceability generics |
| url | https://www.pharmacoeconomics.ru/jour/article/view/230 |
| work_keys_str_mv | AT ovkirsanova optionstooptimizetheaccesstobiosimilarsanalysisandsolutions AT vvomelyanovsky optionstooptimizetheaccesstobiosimilarsanalysisandsolutions |